Ticker brief
PROF
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
16
authors 14d
11
crowd 14d
+0.32
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-08 → 2026-10-14 · now +0.20 (−1 bearish … +1 bullish)
Who spoke11
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @PrismMarketView | C | · | 5 | +0.45 |
| @Greatstockpix | C | -1.40 | 2 | +0.22 |
| @BankTheTrade | C | -0.03 | 1 | +0.50 |
| @Briefingcom | B | -2.26 | 1 | +0.40 |
| @tenet_research | C | -1.23 | 1 | +0.00 |
| @TENETTRADEGROUP | C | -0.65 | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | +0.50 |
| @UTEX_io | C | +0.04 | 1 | +0.50 |
| @PrismDM | A | -2.76 | 1 | +0.40 |
| @CrweWorld | C | · | 1 | +0.25 |
| @zohmbastic | C | -2.94 | 1 | +0.40 |
Recent signals16of 16 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @PrismMarketView | +0.20 | Clinical abstracts show functional benefits but limited long-term validation. | · | tweet ↗ |
| 2026-10-12 | @zohmbastic | +0.40 | Highlights strong relative performance after preliminary earnings. | · | tweet ↗ |
| 2026-10-10 | @PrismMarketView | +0.50 | Reports strong preliminary revenue growth, FDA clearance and sustained MedTech growth. | · | tweet ↗ |
| 2026-10-09 | @PrismMarketView | +0.35 | PROF and TLX partnered on PSMA-informed prostate-cancer care. | · | tweet ↗ |
| 2026-10-09 | @CrweWorld | +0.25 | Profound Medical and Telix entered a co-education agreement for prostate care. | · | tweet ↗ |
| 2026-10-08 | @Greatstockpix | +0.00 | Daily watchlist video lists many tickers but gives no text-level entries or directional views. | · | tweet ↗ |
| 2026-10-08 | @PrismMarketView | +0.50 | Quantifies sector-index and single-stock winners and losers during a risk-off session. | · | tweet ↗ |
| 2026-10-08 | @PrismDM | +0.40 | Reports preliminary record Q3 revenue expected at $9.8M-$10.0M, up about 85%-89% year over year. | · | tweet ↗ |
| 2026-10-08 | @PrismMarketView | +0.70 | Preannounces record Q3 revenue far above prior-year, Q2 and cited consensus levels. | · | tweet ↗ |
| 2026-10-08 | @UTEX_io | +0.50 | Profound Medical's preliminary Q3 revenue guidance topped consensus by roughly 45%-47%. | · | tweet ↗ |
| 2026-10-08 | @OpenOutcrier | +0.50 | Profound Medical forecasts record Q3 revenue far above Street estimates. | · | tweet ↗ |
| 2026-10-08 | @TENETTRADEGROUP | +0.00 | Lists premarket movers without giving direction or catalysts in the text. | · | tweet ↗ |
| 2026-10-08 | @tenet_research | +0.00 | Lists pre-market movers, but the attached image is required for their directions and magnitudes. | · | tweet ↗ |
| 2026-10-08 | @Greatstockpix | +0.45 | Reports Profound Medical announcing strong preliminary Q3 2026 revenue. | · | tweet ↗ |
| 2026-10-08 | @Briefingcom | +0.40 | Lists the largest premarket gaps; output retains the first six tickers under the schema cap. | · | tweet ↗ |
| 2026-10-08 | @BankTheTrade | +0.50 | PROF forecasts Q3 sales well above the analyst estimate | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.